Cargando…
Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer
NF-κB has been linked to doxorubicin resistance in breast cancer patients. NF-κB nuclear translocation and DNA binding in doxorubicin treated-breast cancer cells have been extensively examined; however its functional relevance at transcriptional level on NF-κB -dependent genes and the biological con...
Autores principales: | Dalmases, Alba, González, Irene, Menendez, Silvia, Arpí, Oriol, Corominas, Josep Maria, Servitja, Sonia, Tusquets, Ignasi, Chamizo, Cristina, Rincón, Raúl, Espinosa, Lluis, Bigas, Anna, Eroles, Pilar, Furriol, Jessica, Lluch, Anna, Rovira, Ana, Albanell, Joan, Rojo, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960201/ https://www.ncbi.nlm.nih.gov/pubmed/24344116 |
Ejemplares similares
-
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
por: Rincón, Raúl, et al.
Publicado: (2015) -
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma
por: Rojo, Federico, et al.
Publicado: (2016) -
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
por: Muntasell, Aura, et al.
Publicado: (2017) -
Inhibition of Specific NF-κB Activity Contributes to the Tumor Suppressor Function of 14-3-3σ in Breast Cancer
por: Inglés-Esteve, Julia, et al.
Publicado: (2012) -
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
por: Tormo, Eduardo, et al.
Publicado: (2019)